{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T20:25:13Z","timestamp":1784319913887,"version":"3.55.0"},"publisher-location":"Cham","reference-count":135,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783030855024","type":"print"},{"value":"9783030855031","type":"electronic"}],"license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020]]},"DOI":"10.1007\/7854_2020_169","type":"book-chapter","created":{"date-parts":[[2020,8,6]],"date-time":"2020-08-06T12:07:37Z","timestamp":1596715657000},"page":"193-212","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Pharmacotherapy of Tinnitus"],"prefix":"10.1007","author":[{"given":"Tobias","family":"Kleinjung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berthold","family":"Langguth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,8,7]]},"reference":[{"issue":"9","key":"169_CR1","doi-asserted-by":"publisher","first-page":"e0221713","DOI":"10.1371\/journal.pone.0221713","volume":"14","author":"N Ahmadzai","year":"2019","unstructured":"Ahmadzai N, Kilty S, Cheng W, Esmaeilisaraji L, Wolfe D, Bonaparte JP et al (2019) A systematic review and network meta-analysis of existing pharmacologic therapies in patients with idiopathic sudden sensorineural hearing loss. PLoS One 14(9):e0221713. https:\/\/doi.org\/10.1371\/journal.pone.0221713","journal-title":"PLoS One"},{"issue":"8","key":"169_CR2","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1097\/MAO.0000000000000526","volume":"35","author":"YH An","year":"2014","unstructured":"An YH, Yu KK, Kwak MY, Yoon SW, Shim HJ (2014) Prognostic factors for the outcomes of intratympanic dexamethasone in the treatment of acute subjective tinnitus. Otol Neurotol 35(8):1330\u20131337. https:\/\/doi.org\/10.1097\/MAO.0000000000000526","journal-title":"Otol Neurotol"},{"issue":"1","key":"169_CR3","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/0196-0709(94)90036-1","volume":"15","author":"J Attias","year":"1994","unstructured":"Attias J, Weisz G, Almog S, Shahar A, Wiener M, Joachims Z et al (1994) Oral magnesium intake reduces permanent hearing loss induced by noise exposure. Am J Otolaryngol 15(1):26\u201332. https:\/\/doi.org\/10.1016\/0196-0709(94)90036-1","journal-title":"Am J Otolaryngol"},{"key":"169_CR4","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/S0079-6123(07)66025-7","volume":"166","author":"AA Azevedo","year":"2007","unstructured":"Azevedo AA, Figueiredo RR (2007) Treatment of tinnitus with acamprosate. Prog Brain Res 166:273\u2013277. https:\/\/doi.org\/10.1016\/S0079-6123(07)66025-7","journal-title":"Prog Brain Res"},{"issue":"2","key":"169_CR5","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/s00280-019-04012-z","volume":"85","author":"DM Baguley","year":"2020","unstructured":"Baguley DM, Prayuenyong P (2020) Looking beyond the audiogram in ototoxicity associated with platinum-based chemotherapy. Cancer Chemother Pharmacol 85(2):245\u2013250. https:\/\/doi.org\/10.1007\/s00280-019-04012-z","journal-title":"Cancer Chemother Pharmacol"},{"issue":"2","key":"169_CR6","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1097\/00129492-200503000-00007","volume":"26","author":"DM Baguley","year":"2005","unstructured":"Baguley DM, Jones S, Wilkins I, Axon PR, Moffat DA (2005) The inhibitory effect of intravenous lidocaine infusion on tinnitus after translabyrinthine removal of vestibular schwannoma: a double-blind, placebo-controlled, crossover study. Otol Neurotol 26(2):169\u2013176. https:\/\/doi.org\/10.1097\/00129492-200503000-00007","journal-title":"Otol Neurotol"},{"issue":"9904","key":"169_CR7","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1016\/S0140-6736(13)60142-7","volume":"382","author":"D Baguley","year":"2013","unstructured":"Baguley D, McFerran D, Hall D (2013) Tinnitus. Lancet 382(9904):1600\u20131607. https:\/\/doi.org\/10.1016\/S0140-6736(13)60142-7","journal-title":"Lancet"},{"issue":"2","key":"169_CR8","first-page":"140","volume":"12","author":"FM Bahmad Jr","year":"2006","unstructured":"Bahmad FM Jr, Venosa AR, Oliveira CA (2006) Benzodiazepines and GABAergics in treating severe disabling tinnitus of predominantly cochlear origin. Int Tinnitus J 12(2):140\u2013144. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17260879","journal-title":"Int Tinnitus J"},{"key":"169_CR9","doi-asserted-by":"publisher","first-page":"CD003853","DOI":"10.1002\/14651858.CD003853.pub3","volume":"9","author":"P Baldo","year":"2012","unstructured":"Baldo P, Doree C, Molin P, McFerran D, Cecco S (2012) Antidepressants for patients with tinnitus. Cochrane Database Syst Rev 9:CD003853. https:\/\/doi.org\/10.1002\/14651858.CD003853.pub3","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"169_CR10","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1007\/s101620010030","volume":"2","author":"CA Bauer","year":"2001","unstructured":"Bauer CA, Brozoski TJ (2001) Assessing tinnitus and prospective tinnitus therapeutics using a psychophysical animal model. J Assoc Res Otolaryngol 2(1):54\u201364. https:\/\/doi.org\/10.1007\/s101620010030","journal-title":"J Assoc Res Otolaryngol"},{"issue":"5","key":"169_CR11","doi-asserted-by":"publisher","first-page":"300","DOI":"10.2310\/7070.2001.19597","volume":"30","author":"N Bayar","year":"2001","unstructured":"Bayar N, Boke B, Turan E, Belgin E (2001) Efficacy of amitriptyline in the treatment of subjective tinnitus. J Otolaryngol 30(5):300\u2013303. https:\/\/doi.org\/10.2310\/7070.2001.19597","journal-title":"J Otolaryngol"},{"issue":"12","key":"169_CR12","doi-asserted-by":"publisher","first-page":"2334","DOI":"10.1160\/TH17-05-0356","volume":"117","author":"M Becatti","year":"2017","unstructured":"Becatti M, Marcucci R, Mannucci A, Gori AM, Giusti B, Sofi F et al (2017) Erythrocyte membrane fluidity alterations in sudden sensorineural hearing loss patients: the role of oxidative stress. Thromb Haemost 117(12):2334\u20132345. https:\/\/doi.org\/10.1160\/TH17-05-0356","journal-title":"Thromb Haemost"},{"key":"169_CR13","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.heares.2017.10.012","volume":"356","author":"JI Berger","year":"2017","unstructured":"Berger JI, Coomber B, Hill S, Alexander SPH, Owen W, Palmer AR et al (2017) Effects of the cannabinoid CB1 agonist ACEA on salicylate ototoxicity, hyperacusis and tinnitus in guinea pigs. Hear Res 356:51\u201362. https:\/\/doi.org\/10.1016\/j.heares.2017.10.012","journal-title":"Hear Res"},{"key":"169_CR14","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.neuroscience.2019.02.031","volume":"407","author":"HM Bharadwaj","year":"2019","unstructured":"Bharadwaj HM, Mai AR, Simpson JM, Choi I, Heinz MG, Shinn-Cunningham BG (2019) Non-invasive assays of cochlear synaptopathy \u2013 candidates and considerations. Neuroscience 407:53\u201366. https:\/\/doi.org\/10.1016\/j.neuroscience.2019.02.031","journal-title":"Neuroscience"},{"issue":"1","key":"169_CR15","doi-asserted-by":"publisher","first-page":"4131","DOI":"10.1038\/s41598-019-40425-9","volume":"9","author":"P Bhatta","year":"2019","unstructured":"Bhatta P, Dhukhwa A, Sheehan K, Al Aameri RFH, Borse V, Ghosh S et al (2019) Capsaicin protects against cisplatin ototoxicity by changing the STAT3\/STAT1 ratio and activating cannabinoid (CB2) receptors in the cochlea. Sci Rep 9(1):4131. https:\/\/doi.org\/10.1038\/s41598-019-40425-9","journal-title":"Sci Rep"},{"issue":"5","key":"169_CR16","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1177\/0194599811434504","volume":"146","author":"SK Bhimrao","year":"2012","unstructured":"Bhimrao SK, Masterson L, Baguley D (2012) Systematic review of management strategies for middle ear myoclonus. Otolaryngol Head Neck Surg 146(5):698\u2013706. https:\/\/doi.org\/10.1177\/0194599811434504","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"5","key":"169_CR17","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1159\/000374000","volume":"35","author":"D Bing","year":"2015","unstructured":"Bing D, Lee SC, Campanelli D, Xiong H, Matsumoto M, Panford-Walsh R et al (2015) Cochlear NMDA receptors as a therapeutic target of noise-induced tinnitus. Cell Physiol Biochem 35(5):1905\u20131923. https:\/\/doi.org\/10.1159\/000374000","journal-title":"Cell Physiol Biochem"},{"issue":"7","key":"169_CR18","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1007\/s00115-012-3670-y","volume":"85","author":"U Bonnet","year":"2014","unstructured":"Bonnet U (2014) Decompensated chronic tinnitus and high-dose benzodiazepine dependence. Between Scylla and Charybdis. Nervenarzt 85(7):865\u2013869. https:\/\/doi.org\/10.1007\/s00115-012-3670-y","journal-title":"Nervenarzt"},{"issue":"2","key":"169_CR19","doi-asserted-by":"publisher","first-page":"143","DOI":"10.2165\/00002018-199309020-00006","volume":"9","author":"JA Brien","year":"1993","unstructured":"Brien JA (1993) Ototoxicity associated with salicylates. A brief review. Drug Saf 9(2):143\u2013148. https:\/\/doi.org\/10.2165\/00002018-199309020-00006","journal-title":"Drug Saf"},{"issue":"10","key":"169_CR20","doi-asserted-by":"publisher","first-page":"e77674","DOI":"10.1371\/journal.pone.0077674","volume":"8","author":"TJ Brozoski","year":"2013","unstructured":"Brozoski TJ, Wisner KW, Odintsov B, Bauer CA (2013) Local NMDA receptor blockade attenuates chronic tinnitus and associated brain activity in an animal model. PLoS One 8(10):e77674. https:\/\/doi.org\/10.1371\/journal.pone.0077674","journal-title":"PLoS One"},{"issue":"11","key":"169_CR21","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1038\/nbt.2736","volume":"31","author":"CR Cederroth","year":"2013","unstructured":"Cederroth CR, Canlon B, Langguth B (2013) Hearing loss and tinnitus--are funders and industry listening? Nat Biotechnol 31(11):972\u2013974. https:\/\/doi.org\/10.1038\/nbt.2736","journal-title":"Nat Biotechnol"},{"issue":"4","key":"169_CR22","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1080\/14728214.2018.1555240","volume":"23","author":"CR Cederroth","year":"2018","unstructured":"Cederroth CR, Dyhrfjeld-Johnsen J, Langguth B (2018) An update: emerging drugs for tinnitus. Expert Opin Emerg Drugs 23(4):251\u2013260. https:\/\/doi.org\/10.1080\/14728214.2018.1555240","journal-title":"Expert Opin Emerg Drugs"},{"key":"169_CR23","doi-asserted-by":"publisher","first-page":"53","DOI":"10.3389\/fnagi.2019.00053","volume":"11","author":"CR Cederroth","year":"2019","unstructured":"Cederroth CR, Gallus S, Hall DA, Kleinjung T, Langguth B, Maruotti A et al (2019) Editorial: towards an understanding of tinnitus heterogeneity. Front Aging Neurosci 11:53. https:\/\/doi.org\/10.3389\/fnagi.2019.00053","journal-title":"Front Aging Neurosci"},{"issue":"1_suppl","key":"169_CR24","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1177\/0194599819859885","volume":"161","author":"SS Chandrasekhar","year":"2019","unstructured":"Chandrasekhar SS, Tsai Do BS, Schwartz SR, Bontempo LJ, Faucett EA, Finestone SA et al (2019) Clinical practice guideline: sudden hearing loss (update). Otolaryngol Head Neck Surg 161(1_suppl):S1\u2013S45. https:\/\/doi.org\/10.1177\/0194599819859885","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"6","key":"169_CR25","first-page":"601","volume":"15","author":"G Cianfrone","year":"2011","unstructured":"Cianfrone G, Pentangelo D, Cianfrone F, Mazzei F, Turchetta R, Orlando MP et al (2011) Pharmacological drugs inducing ototoxicity, vestibular symptoms and tinnitus: a reasoned and updated guide. Eur Rev Med Pharmacol Sci 15(6):601\u2013636. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21796866","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"3","key":"169_CR26","doi-asserted-by":"publisher","first-page":"e11868","DOI":"10.2196\/11868","volume":"8","author":"E Clemens","year":"2019","unstructured":"Clemens E, Meijer AJ, Broer L, Langer T, van der Kooi AL, Uitterlinden AG et al (2019a) Genetic determinants of ototoxicity during and after childhood cancer treatment: protocol for the PanCareLIFE study. JMIR Res Protoc 8(3):e11868. https:\/\/doi.org\/10.2196\/11868","journal-title":"JMIR Res Protoc"},{"issue":"1","key":"169_CR27","doi-asserted-by":"publisher","first-page":"e29","DOI":"10.1016\/S1470-2045(18)30858-1","volume":"20","author":"E Clemens","year":"2019","unstructured":"Clemens E, van den Heuvel-Eibrink MM, Mulder RL, Kremer LCM, Hudson MM, Skinner R et al (2019b) Recommendations for ototoxicity surveillance for childhood, adolescent, and young adult cancer survivors: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group in collaboration with the PanCare Consortium. Lancet Oncol 20(1):e29\u2013e41. https:\/\/doi.org\/10.1016\/S1470-2045(18)30858-1","journal-title":"Lancet Oncol"},{"issue":"3","key":"169_CR28","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1159\/000335657","volume":"17","author":"C Coelho","year":"2012","unstructured":"Coelho C, Figueiredo R, Frank E, Burger J, Schecklmann M, Landgrebe M et al (2012) Reduction of tinnitus severity by the centrally acting muscle relaxant cyclobenzaprine: an open-label pilot study. Audiol Neurootol 17(3):179\u2013188. https:\/\/doi.org\/10.1159\/000335657","journal-title":"Audiol Neurootol"},{"key":"169_CR29","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.ijporl.2018.09.024","volume":"116","author":"J Dang","year":"2019","unstructured":"Dang J, Carol Liu YC (2019) Treatment of objective tinnitus with transpalatal Botox((R)) injection in a pediatric patient with middle ear myoclonus: a case report. Int J Pediatr Otorhinolaryngol 116:22\u201324. https:\/\/doi.org\/10.1016\/j.ijporl.2018.09.024","journal-title":"Int J Pediatr Otorhinolaryngol"},{"issue":"5","key":"169_CR30","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1097\/MAO.0b013e3181ab8fd5","volume":"30","author":"AA de Azevedo","year":"2009","unstructured":"de Azevedo AA, Langguth B, de Oliveira PM, Rodrigues Figueiredo R (2009) Tinnitus treatment with piribedil guided by electrocochleography and acoustic otoemissions. Otol Neurotol 30(5):676\u2013680. https:\/\/doi.org\/10.1097\/MAO.0b013e3181ab8fd5","journal-title":"Otol Neurotol"},{"issue":"20","key":"169_CR31","doi-asserted-by":"publisher","first-page":"8075","DOI":"10.1073\/pnas.1018466108","volume":"108","author":"D De Ridder","year":"2011","unstructured":"De Ridder D, Elgoyhen AB, Romo R, Langguth B (2011) Phantom percepts: tinnitus and pain as persisting aversive memory networks. Proc Natl Acad Sci U S A 108(20):8075\u20138080. https:\/\/doi.org\/10.1073\/pnas.1018466108","journal-title":"Proc Natl Acad Sci U S A"},{"key":"169_CR32","doi-asserted-by":"publisher","first-page":"124","DOI":"10.3389\/fneur.2015.00124","volume":"6","author":"D De Ridder","year":"2015","unstructured":"De Ridder D, Vanneste S, Langguth B, Llinas R (2015) Thalamocortical dysrhythmia: a theoretical update in tinnitus. Front Neurol 6:124. https:\/\/doi.org\/10.3389\/fneur.2015.00124","journal-title":"Front Neurol"},{"issue":"4","key":"169_CR33","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1177\/014556131109000405","volume":"90","author":"MA Dehkordi","year":"2011","unstructured":"Dehkordi MA, Abolbashari S, Taheri R, Einolghozati S (2011) Efficacy of gabapentin on subjective idiopathic tinnitus: a randomized, double-blind, placebo-controlled trial. Ear Nose Throat J 90(4):150\u2013158. https:\/\/doi.org\/10.1177\/014556131109000405","journal-title":"Ear Nose Throat J"},{"issue":"6","key":"169_CR34","doi-asserted-by":"publisher","first-page":"825","DOI":"10.3109\/00016489709114208","volume":"117","author":"DM Denk","year":"1997","unstructured":"Denk DM, Heinzl H, Franz P, Ehrenberger K (1997) Caroverine in tinnitus treatment. A placebo-controlled blind study. Acta Otolaryngol 117(6):825\u2013830. https:\/\/doi.org\/10.3109\/00016489709114208","journal-title":"Acta Otolaryngol"},{"issue":"1\u20132","key":"169_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/s0378-5955(02)00585-3","volume":"173","author":"D Ding","year":"2002","unstructured":"Ding D, McFadden SL, Woo JM, Salvi RJ (2002) Ethacrynic acid rapidly and selectively abolishes blood flow in vessels supplying the lateral wall of the cochlea. Hear Res 173(1\u20132):1\u20139. https:\/\/doi.org\/10.1016\/s0378-5955(02)00585-3","journal-title":"Hear Res"},{"issue":"8","key":"169_CR36","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1097\/00005537-199908000-00004","volume":"109","author":"RA Dobie","year":"1999","unstructured":"Dobie RA (1999) A review of randomized clinical trials in tinnitus. Laryngoscope 109(8):1202\u20131211. https:\/\/doi.org\/10.1097\/00005537-199908000-00004","journal-title":"Laryngoscope"},{"issue":"4","key":"169_CR37","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1080\/00016489850154801","volume":"118","author":"H Domeisen","year":"1998","unstructured":"Domeisen H, Hotz MA, Hausler R (1998) Caroverine in tinnitus treatment. Acta Otolaryngol 118(4):606\u2013608. https:\/\/doi.org\/10.1080\/00016489850154801","journal-title":"Acta Otolaryngol"},{"issue":"2","key":"169_CR38","doi-asserted-by":"publisher","first-page":"S162","DOI":"10.1044\/1059-0889(2008\/07-0025)","volume":"17","author":"JJ Eggermont","year":"2008","unstructured":"Eggermont JJ (2008) Role of auditory cortex in noise- and drug-induced tinnitus. Am J Audiol 17(2):S162\u2013S169. https:\/\/doi.org\/10.1044\/1059-0889(2008\/07-0025)","journal-title":"Am J Audiol"},{"issue":"1","key":"169_CR39","first-page":"34","volume":"11","author":"K Ehrenberger","year":"2005","unstructured":"Ehrenberger K (2005) Topical administration of Caroverine in somatic tinnitus treatment: proof-of-concept study. Int Tinnitus J 11(1):34\u201337. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16419686","journal-title":"Int Tinnitus J"},{"key":"169_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fnsys.2012.00001","volume":"6","author":"AB Elgoyhen","year":"2012","unstructured":"Elgoyhen AB, Langguth B, Vanneste S, De Ridder D (2012) Tinnitus: network pathophysiology-network pharmacology. Front Syst Neurosci 6:1. https:\/\/doi.org\/10.3389\/fnsys.2012.00001","journal-title":"Front Syst Neurosci"},{"key":"169_CR41","doi-asserted-by":"publisher","first-page":"e97","DOI":"10.1038\/psp.2013.75","volume":"3","author":"AB Elgoyhen","year":"2014","unstructured":"Elgoyhen AB, Langguth B, Nowak W, Schecklmann M, De Ridder D, Vanneste S (2014) Identifying tinnitus-related genes based on a side-effect network analysis. CPT Pharmacometrics Syst Pharmacol 3:e97. https:\/\/doi.org\/10.1038\/psp.2013.75","journal-title":"CPT Pharmacometrics Syst Pharmacol"},{"issue":"6","key":"169_CR42","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1007\/s11064-011-0455-9","volume":"36","author":"H Feng","year":"2011","unstructured":"Feng H, Yin SH, Tang AZ, Tan SH (2011) Salicylate initiates apoptosis in the spiral ganglion neuron of guinea pig cochlea by activating caspase-3. Neurochem Res 36(6):1108\u20131115. https:\/\/doi.org\/10.1007\/s11064-011-0455-9","journal-title":"Neurochem Res"},{"issue":"4","key":"169_CR43","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/j.otohns.2007.11.027","volume":"138","author":"RR Figueiredo","year":"2008","unstructured":"Figueiredo RR, Langguth B, Mello de Oliveira P, Aparecida de Azevedo A (2008) Tinnitus treatment with memantine. Otolaryngol Head Neck Surg 138(4):492\u2013496. https:\/\/doi.org\/10.1016\/j.otohns.2007.11.027","journal-title":"Otolaryngol Head Neck Surg"},{"key":"169_CR44","doi-asserted-by":"publisher","first-page":"280","DOI":"10.3389\/fncel.2017.00280","volume":"11","author":"AE Fransson","year":"2017","unstructured":"Fransson AE, Kisiel M, Pirttila K, Pettersson C, Videhult Pierre P, Laurell GFE (2017) Hydrogen inhalation protects against ototoxicity induced by intravenous cisplatin in the guinea pig. Front Cell Neurosci 11:280. https:\/\/doi.org\/10.3389\/fncel.2017.00280","journal-title":"Front Cell Neurosci"},{"issue":"3","key":"169_CR45","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1007\/s00405-016-4301-1","volume":"274","author":"F Gul","year":"2017","unstructured":"Gul F, Muderris T, Yalciner G, Sevil E, Bercin S, Ergin M et al (2017) A comprehensive study of oxidative stress in sudden hearing loss. Eur Arch Otorhinolaryngol 274(3):1301\u20131308. https:\/\/doi.org\/10.1007\/s00405-016-4301-1","journal-title":"Eur Arch Otorhinolaryngol"},{"issue":"8","key":"169_CR46","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1136\/jnnp-2012-302273","volume":"83","author":"SS Han","year":"2012","unstructured":"Han SS, Nam EC, Won JY, Lee KU, Chun W, Choi HK et al (2012) Clonazepam quiets tinnitus: a randomised crossover study with Ginkgo biloba. J Neurol Neurosurg Psychiatry 83(8):821\u2013827. https:\/\/doi.org\/10.1136\/jnnp-2012-302273","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"10","key":"169_CR47","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1007\/s00106-010-2179-6","volume":"58","author":"G Hesse","year":"2010","unstructured":"Hesse G, Laubert A (2010) Pharmacotherapy of acute and chronic hearing loss. HNO 58(10):990\u2013998. https:\/\/doi.org\/10.1007\/s00106-010-2179-6","journal-title":"HNO"},{"key":"169_CR48","doi-asserted-by":"publisher","first-page":"CD007960","DOI":"10.1002\/14651858.CD007960.pub2","volume":"7","author":"CE Hoekstra","year":"2011","unstructured":"Hoekstra CE, Rynja SP, van Zanten GA, Rovers MM (2011) Anticonvulsants for tinnitus. Cochrane Database Syst Rev 7:CD007960. https:\/\/doi.org\/10.1002\/14651858.CD007960.pub2","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"169_CR49","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1159\/000275781","volume":"47","author":"JH Hulshof","year":"1985","unstructured":"Hulshof JH, Vermeij P (1985) The value of carbamazepine in the treatment of tinnitus. ORL J Otorhinolaryngol Relat Spec 47(5):262\u2013266. https:\/\/doi.org\/10.1159\/000275781","journal-title":"ORL J Otorhinolaryngol Relat Spec"},{"issue":"2","key":"169_CR50","doi-asserted-by":"publisher","first-page":"90","DOI":"10.7874\/jao.2016.20.2.90","volume":"20","author":"SM Hwang","year":"2016","unstructured":"Hwang SM, Lim SH, Oh DJ, Kim SK, Jung HH, Im GJ (2016) Effect of tianeptine on depressed tinnitus patients. J Audiol Otol 20(2):90\u201396. https:\/\/doi.org\/10.7874\/jao.2016.20.2.90","journal-title":"J Audiol Otol"},{"issue":"11","key":"169_CR51","first-page":"PI55","volume":"15","author":"MM Jalali","year":"2009","unstructured":"Jalali MM, Kousha A, Naghavi SE, Soleimani R, Banan R (2009) The effects of alprazolam on tinnitus: a cross-over randomized clinical trial. Med Sci Monit 15(11):PI55\u2013PI60. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19865063","journal-title":"Med Sci Monit"},{"issue":"8","key":"169_CR52","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1001\/archotol.1993.01880200042006","volume":"119","author":"RM Johnson","year":"1993","unstructured":"Johnson RM, Brummett R, Schleuning A (1993) Use of alprazolam for relief of tinnitus. A double-blind study. Arch Otolaryngol Head Neck Surg 119(8):842\u2013845. https:\/\/doi.org\/10.1001\/archotol.1993.01880200042006","journal-title":"Arch Otolaryngol Head Neck Surg"},{"issue":"2","key":"169_CR53","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1055\/s-0038-1676308","volume":"80","author":"JS Juan","year":"2019","unstructured":"Juan JS, Basura GJ (2019) Tinnitus management in lateral skull base lesions. J Neurol Surg B Skull Base 80(2):125\u2013131. https:\/\/doi.org\/10.1055\/s-0038-1676308","journal-title":"J Neurol Surg B Skull Base"},{"issue":"Suppl 3","key":"169_CR54","doi-asserted-by":"publisher","first-page":"S14","DOI":"10.1017\/S0022215115000808","volume":"129","author":"NE Jufas","year":"2015","unstructured":"Jufas NE, Wood R (2015) The use of benzodiazepines for tinnitus: systematic review. J Laryngol Otol 129(Suppl 3):S14\u2013S22. https:\/\/doi.org\/10.1017\/S0022215115000808","journal-title":"J Laryngol Otol"},{"issue":"5","key":"169_CR55","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1002\/lary.26191","volume":"127","author":"TM Kaffenberger","year":"2017","unstructured":"Kaffenberger TM, Mandal R, Schaitkin BM, Hirsch BE (2017) Palatal botulinum toxin as a novel therapy for objective tinnitus in forced eyelid closure syndrome. Laryngoscope 127(5):1199\u20131201. https:\/\/doi.org\/10.1002\/lary.26191","journal-title":"Laryngoscope"},{"issue":"23","key":"169_CR56","doi-asserted-by":"publisher","first-page":"8829","DOI":"10.1523\/JNEUROSCI.5176-14.2015","volume":"35","author":"BI Kalappa","year":"2015","unstructured":"Kalappa BI, Soh H, Duignan KM, Furuya T, Edwards S, Tzingounis AV et al (2015) Potent KCNQ2\/3-specific channel activator suppresses in vivo epileptic activity and prevents the development of tinnitus. J Neurosci 35(23):8829\u20138842. https:\/\/doi.org\/10.1523\/JNEUROSCI.5176-14.2015","journal-title":"J Neurosci"},{"key":"169_CR57","doi-asserted-by":"publisher","first-page":"87","DOI":"10.5152\/iao.2020.7062","volume":"16","author":"E Kara","year":"2020","unstructured":"Kara E, Aydin K, Akbulut AA, Karakol SN, Durmaz S, Yener HM et al (2020) Assessment of hidden hearing loss in normal hearing individuals with and without tinnitus. J Int Adv Otol 16:87. https:\/\/doi.org\/10.5152\/iao.2020.7062","journal-title":"J Int Adv Otol"},{"issue":"2","key":"169_CR58","doi-asserted-by":"publisher","first-page":"123","DOI":"10.3109\/03005368109081425","volume":"15","author":"NJ Kay","year":"1981","unstructured":"Kay NJ (1981) Oral chemotherapy in tinnitus. Br J Audiol 15(2):123\u2013124. https:\/\/doi.org\/10.3109\/03005368109081425","journal-title":"Br J Audiol"},{"key":"169_CR59","doi-asserted-by":"publisher","unstructured":"Kleinjung T, Langguth B (2020) Avenue for future tinnitus treatments. Otolaryngol Clin North Am. https:\/\/doi.org\/10.1016\/j.otc.2020.03.013","DOI":"10.1016\/j.otc.2020.03.013"},{"issue":"2","key":"169_CR60","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.amjoto.2008.11.007","volume":"31","author":"E Krause","year":"2010","unstructured":"Krause E, Heinen F, Gurkov R (2010) Difference in outcome of botulinum toxin treatment of essential palatal tremor in children and adults. Am J Otolaryngol 31(2):91\u201395. https:\/\/doi.org\/10.1016\/j.amjoto.2008.11.007","journal-title":"Am J Otolaryngol"},{"issue":"2","key":"169_CR61","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1038\/s41419-019-1386-7","volume":"10","author":"K Kucharava","year":"2019","unstructured":"Kucharava K, Sekulic-Jablanovic M, Horvath L, Bodmer D, Petkovic V (2019) Pasireotide protects mammalian cochlear hair cells from gentamicin ototoxicity by activating the PI3K-Akt pathway. Cell Death Dis 10(2):110. https:\/\/doi.org\/10.1038\/s41419-019-1386-7","journal-title":"Cell Death Dis"},{"issue":"6","key":"169_CR62","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1124\/mol.115.103200","volume":"89","author":"M Kumar","year":"2016","unstructured":"Kumar M, Reed N, Liu R, Aizenman E, Wipf P, Tzounopoulos T (2016) Synthesis and evaluation of potent KCNQ2\/3-specific channel activators. Mol Pharmacol 89(6):667\u2013677. https:\/\/doi.org\/10.1124\/mol.115.103200","journal-title":"Mol Pharmacol"},{"key":"169_CR63","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/1472-6947-10-42","volume":"10","author":"M Landgrebe","year":"2010","unstructured":"Landgrebe M, Zeman F, Koller M, Eberl Y, Mohr M, Reiter J et al (2010) The Tinnitus Research Initiative (TRI) database: a new approach for delineation of tinnitus subtypes and generation of predictors for treatment outcome. BMC Med Inform Decis Mak 10:42. https:\/\/doi.org\/10.1186\/1472-6947-10-42","journal-title":"BMC Med Inform Decis Mak"},{"issue":"11","key":"169_CR64","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1002\/cncr.29779","volume":"122","author":"W Landier","year":"2016","unstructured":"Landier W (2016) Ototoxicity and cancer therapy. Cancer 122(11):1647\u20131658. https:\/\/doi.org\/10.1002\/cncr.29779","journal-title":"Cancer"},{"issue":"8","key":"169_CR65","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/j.tips.2013.05.006","volume":"34","author":"T Langer","year":"2013","unstructured":"Langer T, am Zehnhoff-Dinnesen A, Radtke S, Meitert J, Zolk O (2013) Understanding platinum-induced ototoxicity. Trends Pharmacol Sci 34(8):458\u2013469. https:\/\/doi.org\/10.1016\/j.tips.2013.05.006","journal-title":"Trends Pharmacol Sci"},{"issue":"7","key":"169_CR66","doi-asserted-by":"publisher","first-page":"489","DOI":"10.3109\/15622975.2011.575178","volume":"12","author":"B Langguth","year":"2011","unstructured":"Langguth B, Landgrebe M, Kleinjung T, Sand GP, Hajak G (2011) Tinnitus and depression. World J Biol Psychiatry 12(7):489\u2013500. https:\/\/doi.org\/10.3109\/15622975.2011.575178","journal-title":"World J Biol Psychiatry"},{"issue":"9","key":"169_CR67","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1016\/S1474-4422(13)70160-1","volume":"12","author":"B Langguth","year":"2013","unstructured":"Langguth B, Kreuzer PM, Kleinjung T, De Ridder D (2013) Tinnitus: causes and clinical management. Lancet Neurol 12(9):920\u2013930. https:\/\/doi.org\/10.1016\/S1474-4422(13)70160-1","journal-title":"Lancet Neurol"},{"issue":"3","key":"169_CR68","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1517\/14728222.2016.1125884","volume":"20","author":"B Langguth","year":"2016","unstructured":"Langguth B, Elgoyhen AB, Schlee W (2016) Potassium channels as promising new targets for pharmacologic treatment of tinnitus: can Internet-based \u2018crowd sensing\u2019 initiated by patients speed up the transition from bench to bedside? Expert Opin Ther Targets 20(3):251\u2013254. https:\/\/doi.org\/10.1517\/14728222.2016.1125884","journal-title":"Expert Opin Ther Targets"},{"key":"169_CR69","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1146\/annurev-pharmtox-010818-021556","volume":"59","author":"B Langguth","year":"2019","unstructured":"Langguth B, Elgoyhen AB, Cederroth CR (2019) Therapeutic approaches to the treatment of tinnitus. Annu Rev Pharmacol Toxicol 59:291\u2013313. https:\/\/doi.org\/10.1146\/annurev-pharmtox-010818-021556","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"9","key":"169_CR70","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1007\/s00405-015-3689-3","volume":"273","author":"P Lavigne","year":"2016","unstructured":"Lavigne P, Lavigne F, Saliba I (2016) Intratympanic corticosteroids injections: a systematic review of literature. Eur Arch Otorhinolaryngol 273(9):2271\u20132278. https:\/\/doi.org\/10.1007\/s00405-015-3689-3","journal-title":"Eur Arch Otorhinolaryngol"},{"issue":"2","key":"169_CR71","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1055\/s-0039-1684045","volume":"40","author":"CG Le Prell","year":"2019","unstructured":"Le Prell CG (2019) Otoprotectants: from research to clinical application. Semin Hear 40(2):162\u2013176. https:\/\/doi.org\/10.1055\/s-0039-1684045","journal-title":"Semin Hear"},{"issue":"1","key":"169_CR72","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1002\/lary.26541","volume":"128","author":"HJ Lee","year":"2018","unstructured":"Lee HJ, Kim MB, Yoo SY, Park SN, Nam EC, Moon IS et al (2018) Clinical effect of intratympanic dexamethasone injection in acute unilateral tinnitus: a prospective, placebo-controlled, multicenter study. Laryngoscope 128(1):184\u2013188. https:\/\/doi.org\/10.1002\/lary.26541","journal-title":"Laryngoscope"},{"issue":"6","key":"169_CR73","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1111\/coa.13435","volume":"44","author":"J Lefeuvre","year":"2019","unstructured":"Lefeuvre J, Chedeau J, Boulet M, Fain G, Papon JF, Nguyen Y et al (2019) Hidden hearing loss and tinnitus: utility of the high-definition audiograms in diagnosis. Clin Otolaryngol 44(6):1170\u20131175. https:\/\/doi.org\/10.1111\/coa.13435","journal-title":"Clin Otolaryngol"},{"key":"169_CR74","doi-asserted-by":"publisher","first-page":"m976","DOI":"10.1136\/bmj.m976","volume":"368","author":"S Lewis","year":"2020","unstructured":"Lewis S, Chowdhury E, Stockdale D, Kennedy V, Guideline C (2020) Assessment and management of tinnitus: summary of NICE guidance. BMJ 368:m976. https:\/\/doi.org\/10.1136\/bmj.m976","journal-title":"BMJ"},{"key":"169_CR75","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.heares.2017.01.003","volume":"349","author":"MC Liberman","year":"2017","unstructured":"Liberman MC, Kujawa SG (2017) Cochlear synaptopathy in acquired sensorineural hearing loss: manifestations and mechanisms. Hear Res 349:138\u2013147. https:\/\/doi.org\/10.1016\/j.heares.2017.01.003","journal-title":"Hear Res"},{"issue":"9","key":"169_CR76","doi-asserted-by":"publisher","first-page":"e0162726","DOI":"10.1371\/journal.pone.0162726","volume":"11","author":"MC Liberman","year":"2016","unstructured":"Liberman MC, Epstein MJ, Cleveland SS, Wang H, Maison SF (2016) Toward a differential diagnosis of hidden hearing loss in humans. PLoS One 11(9):e0162726. https:\/\/doi.org\/10.1371\/journal.pone.0162726","journal-title":"PLoS One"},{"issue":"1","key":"169_CR77","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.clineuro.2010.07.022","volume":"113","author":"HB Liu","year":"2011","unstructured":"Liu HB, Fan JP, Lin SZ, Zhao SW, Lin Z (2011) Botox transient treatment of tinnitus due to stapedius myoclonus: case report. Clin Neurol Neurosurg 113(1):57\u201358. https:\/\/doi.org\/10.1016\/j.clineuro.2010.07.022","journal-title":"Clin Neurol Neurosurg"},{"key":"169_CR78","doi-asserted-by":"publisher","unstructured":"Lopez-Escamez JA, Amanat S (2020) Heritability and genetics contribution to tinnitus. Otolaryngol Clin North Am. https:\/\/doi.org\/10.1016\/j.otc.2020.03.003","DOI":"10.1016\/j.otc.2020.03.003"},{"issue":"1","key":"169_CR79","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.anl.2006.09.021","volume":"34","author":"MA Lopez-Gonzalez","year":"2007","unstructured":"Lopez-Gonzalez MA, Moliner-Peiro F, Alfaro-Garcia J, Esteban-Ortega F (2007a) Sulpiride plus hydroxyzine decrease tinnitus perception. Auris Nasus Larynx 34(1):23\u201327. https:\/\/doi.org\/10.1016\/j.anl.2006.09.021","journal-title":"Auris Nasus Larynx"},{"issue":"4","key":"169_CR80","doi-asserted-by":"publisher","first-page":"213","DOI":"10.2310\/7070.2007.0018","volume":"36","author":"MA Lopez-Gonzalez","year":"2007","unstructured":"Lopez-Gonzalez MA, Santiago AM, Esteban-Ortega F (2007b) Sulpiride and melatonin decrease tinnitus perception modulating the auditolimbic dopaminergic pathway. J Otolaryngol 36(4):213\u2013219. https:\/\/doi.org\/10.2310\/7070.2007.0018","journal-title":"J Otolaryngol"},{"issue":"1\u20132","key":"169_CR81","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.heares.2004.08.002","volume":"201","author":"ED Lynch","year":"2005","unstructured":"Lynch ED, Gu R, Pierce C, Kil J (2005) Reduction of acute cisplatin ototoxicity and nephrotoxicity in rats by oral administration of allopurinol and ebselen. Hear Res 201(1\u20132):81\u201389. https:\/\/doi.org\/10.1016\/j.heares.2004.08.002","journal-title":"Hear Res"},{"key":"169_CR82","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3389\/fnagi.2015.00003","volume":"7","author":"B Malgrange","year":"2015","unstructured":"Malgrange B, Varela-Nieto I, de Medina P, Paillasse MR (2015) Targeting cholesterol homeostasis to fight hearing loss: a new perspective. Front Aging Neurosci 7:3. https:\/\/doi.org\/10.3389\/fnagi.2015.00003","journal-title":"Front Aging Neurosci"},{"issue":"24","key":"169_CR83","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1056\/nejm198712103172418","volume":"317","author":"MK Mardini","year":"1987","unstructured":"Mardini MK (1987) Ear-clicking \u201ctinnitus\u201d responding to carbamazepine. N Engl J Med 317(24):1542. https:\/\/doi.org\/10.1056\/nejm198712103172418","journal-title":"N Engl J Med"},{"issue":"2 Pt 1","key":"169_CR84","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1177\/000348948809700204","volume":"97","author":"RC Mihail","year":"1988","unstructured":"Mihail RC, Crowley JM, Walden BE, Fishburne J, Reinwall JE, Zajtchuk JT (1988) The tricyclic trimipramine in the treatment of subjective tinnitus. Ann Otol Rhinol Laryngol 97(2 Pt 1):120\u2013123. https:\/\/doi.org\/10.1177\/000348948809700204","journal-title":"Ann Otol Rhinol Laryngol"},{"issue":"3","key":"169_CR85","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1038\/nrd.2017.244","volume":"17","author":"P Morgan","year":"2018","unstructured":"Morgan P, Brown DG, Lennard S, Anderton MJ, Barrett JC, Eriksson U et al (2018) Impact of a five-dimensional framework on R&D productivity at AstraZeneca. Nat Rev Drug Discov 17(3):167\u2013181. https:\/\/doi.org\/10.1038\/nrd.2017.244","journal-title":"Nat Rev Drug Discov"},{"key":"169_CR86","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.heares.2016.11.010","volume":"344","author":"BT Paul","year":"2017","unstructured":"Paul BT, Bruce IC, Roberts LE (2017) Evidence that hidden hearing loss underlies amplitude modulation encoding deficits in individuals with and without tinnitus. Hear Res 344:170\u2013182. https:\/\/doi.org\/10.1016\/j.heares.2016.11.010","journal-title":"Hear Res"},{"key":"169_CR87","doi-asserted-by":"publisher","first-page":"CD009832","DOI":"10.1002\/14651858.CD009832.pub2","volume":"11","author":"OC Person","year":"2016","unstructured":"Person OC, Puga ME, da Silva EM, Torloni MR (2016) Zinc supplementation for tinnitus. Cochrane Database Syst Rev 11:CD009832. https:\/\/doi.org\/10.1002\/14651858.CD009832.pub2","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"169_CR88","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1001\/archotol.133.4.390","volume":"133","author":"JF Piccirillo","year":"2007","unstructured":"Piccirillo JF, Finnell J, Vlahiotis A, Chole RA, Spitznagel E Jr (2007) Relief of idiopathic subjective tinnitus: is gabapentin effective? Arch Otolaryngol Head Neck Surg 133(4):390\u2013397. https:\/\/doi.org\/10.1001\/archotol.133.4.390","journal-title":"Arch Otolaryngol Head Neck Surg"},{"issue":"1","key":"169_CR89","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1111\/coa.13457","volume":"45","author":"P Prayuenyong","year":"2020","unstructured":"Prayuenyong P, Kasbekar AV, Baguley DM (2020) The efficacy of statins as otoprotective agents: a systematic review. Clin Otolaryngol 45(1):21\u201331. https:\/\/doi.org\/10.1111\/coa.13457","journal-title":"Clin Otolaryngol"},{"issue":"6","key":"169_CR90","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/0301-0082(95)00028-3","volume":"47","author":"JL Puel","year":"1995","unstructured":"Puel JL (1995) Chemical synaptic transmission in the cochlea. Prog Neurobiol 47(6):449\u2013476. https:\/\/doi.org\/10.1016\/0301-0082(95)00028-3","journal-title":"Prog Neurobiol"},{"issue":"1","key":"169_CR91","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1159\/000046864","volume":"7","author":"JL Puel","year":"2002","unstructured":"Puel JL, Ruel J, Guitton M, Wang J, Pujol R (2002) The inner hair cell synaptic complex: physiology, pharmacology and new therapeutic strategies. Audiol Neurootol 7(1):49\u201354. https:\/\/doi.org\/10.1159\/000046864","journal-title":"Audiol Neurootol"},{"key":"169_CR92","volume-title":"Tinnitus \u2013 clinical and research perspectives","author":"KH Radziwon","year":"2016","unstructured":"Radziwon KH, Hayes SH, Sheppard AM, Ding D, Salvi R (2016) Drug-induced tinnitus. In: Baguley D (ed) Tinnitus \u2013 clinical and research perspectives. Plural Publishing, San Diego"},{"issue":"3","key":"169_CR93","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.anorl.2019.12.004","volume":"137","author":"P Reynard","year":"2019","unstructured":"Reynard P, Ionescu E, Karkas A, Ltaeif-Boudrigua A, Thai-Van H (2019) Unilateral cochleovestibular nerve compression syndrome in a patient with bilateral IAC osteoma. Eur Ann Otorhinolaryngol Head Neck Dis 137(3):213\u2013216. https:\/\/doi.org\/10.1016\/j.anorl.2019.12.004","journal-title":"Eur Ann Otorhinolaryngol Head Neck Dis"},{"issue":"6","key":"169_CR94","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1097\/01.psy.0000188479.04891.74","volume":"67","author":"SK Robinson","year":"2005","unstructured":"Robinson SK, Viirre ES, Bailey KA, Gerke MA, Harris JP, Stein MB (2005) Randomized placebo-controlled trial of a selective serotonin reuptake inhibitor in the treatment of nondepressed tinnitus subjects. Psychosom Med 67(6):981\u2013988. https:\/\/doi.org\/10.1097\/01.psy.0000188479.04891.74","journal-title":"Psychosom Med"},{"issue":"3","key":"169_CR95","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1080\/14992027.2018.1543961","volume":"58","author":"U Rosenhall","year":"2019","unstructured":"Rosenhall U, Skoog B, Muhr P (2019) Treatment of military acoustic accidents with N-acetyl-L-cysteine (NAC). Int J Audiol 58(3):151\u2013157. https:\/\/doi.org\/10.1080\/14992027.2018.1543961","journal-title":"Int J Audiol"},{"issue":"5","key":"169_CR96","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/S0030-6665(20)30770-2","volume":"26","author":"LP Rybak","year":"1993","unstructured":"Rybak LP (1993) Ototoxicity of loop diuretics. Otolaryngol Clin N Am 26(5):829\u2013844. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8233492","journal-title":"Otolaryngol Clin N Am"},{"issue":"4","key":"169_CR97","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1016\/j.amjoto.2019.03.017","volume":"40","author":"PP Salehi","year":"2019","unstructured":"Salehi PP, Kasle D, Torabi SJ, Michaelides E, Hildrew DM (2019) The etiology, pathogeneses, and treatment of objective tinnitus: unique case series and literature review. Am J Otolaryngol 40(4):594\u2013597. https:\/\/doi.org\/10.1016\/j.amjoto.2019.03.017","journal-title":"Am J Otolaryngol"},{"key":"169_CR98","doi-asserted-by":"publisher","first-page":"111079","DOI":"10.1016\/j.fct.2019.111079","volume":"136","author":"N Santos","year":"2020","unstructured":"Santos N, Ferreira RS, Santos ACD (2020) Overview of cisplatin-induced neurotoxicity and ototoxicity, and the protective agents. Food Chem Toxicol 136:111079. https:\/\/doi.org\/10.1016\/j.fct.2019.111079","journal-title":"Food Chem Toxicol"},{"issue":"1","key":"169_CR99","doi-asserted-by":"publisher","first-page":"40","DOI":"10.5935\/0946-5448.20180007","volume":"22","author":"Z Sarafraz","year":"2018","unstructured":"Sarafraz Z, Ahmadi A, Daneshi A (2018) Transtympanic injections of N-acetylcysteine and dexamethasone for prevention of cisplatin-induced ototoxicity: double blind randomized clinical trial. Int Tinnitus J 22(1):40\u201345. https:\/\/doi.org\/10.5935\/0946-5448.20180007","journal-title":"Int Tinnitus J"},{"issue":"3","key":"169_CR100","doi-asserted-by":"publisher","first-page":"198","DOI":"10.2165\/00002018-199614030-00006","volume":"14","author":"H Seligmann","year":"1996","unstructured":"Seligmann H, Podoshin L, Ben-David J, Fradis M, Goldsher M (1996) Drug-induced tinnitus and other hearing disorders. Drug Saf 14(3):198\u2013212. https:\/\/doi.org\/10.2165\/00002018-199614030-00006","journal-title":"Drug Saf"},{"issue":"4","key":"169_CR101","first-page":"244","volume":"19","author":"I Sendowski","year":"2006","unstructured":"Sendowski I (2006) Magnesium therapy in acoustic trauma. Magnes Res 19(4):244\u2013254. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17402292","journal-title":"Magnes Res"},{"issue":"1","key":"169_CR102","doi-asserted-by":"publisher","first-page":"93","DOI":"10.4103\/0253-7613.91876","volume":"44","author":"DK Sharma","year":"2012","unstructured":"Sharma DK, Kaur S, Singh J, Kaur I (2012) Role of acamprosate in sensorineural tinnitus. Indian J Pharmacol 44(1):93\u201396. https:\/\/doi.org\/10.4103\/0253-7613.91876","journal-title":"Indian J Pharmacol"},{"key":"169_CR103","doi-asserted-by":"publisher","first-page":"338","DOI":"10.3389\/fncel.2017.00338","volume":"11","author":"S Sheth","year":"2017","unstructured":"Sheth S, Mukherjea D, Rybak LP, Ramkumar V (2017) Mechanisms of cisplatin-induced ototoxicity and otoprotection. Front Cell Neurosci 11:338. https:\/\/doi.org\/10.3389\/fncel.2017.00338","journal-title":"Front Cell Neurosci"},{"issue":"1","key":"169_CR104","doi-asserted-by":"publisher","first-page":"53","DOI":"10.5152\/iao.2016.2632","volume":"13","author":"HJ Shim","year":"2017","unstructured":"Shim HJ, Lee ES, An YH, Kim DH (2017) Comparison of long-term outcome of intratympanic dexamethasone therapy between acute noise-induced tinnitus and acute idiopathic tinnitus. J Int Adv Otol 13(1):53\u201360. https:\/\/doi.org\/10.5152\/iao.2016.2632","journal-title":"J Int Adv Otol"},{"issue":"1","key":"169_CR105","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.neuron.2019.05.008","volume":"103","author":"SE Shore","year":"2019","unstructured":"Shore SE, Wu C (2019) Mechanisms of noise-induced tinnitus: insights from cellular studies. Neuron 103(1):8\u201320. https:\/\/doi.org\/10.1016\/j.neuron.2019.05.008","journal-title":"Neuron"},{"issue":"3","key":"169_CR106","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1038\/nrneurol.2016.12","volume":"12","author":"SE Shore","year":"2016","unstructured":"Shore SE, Roberts LE, Langguth B (2016) Maladaptive plasticity in tinnitus--triggers, mechanisms and treatment. Nat Rev Neurol 12(3):150\u2013160. https:\/\/doi.org\/10.1038\/nrneurol.2016.12","journal-title":"Nat Rev Neurol"},{"issue":"5","key":"169_CR107","first-page":"627","volume":"20","author":"JJ Simpson","year":"1999","unstructured":"Simpson JJ, Gilbert AM, Weiner GM, Davies WE (1999) The assessment of lamotrigine, an antiepileptic drug, in the treatment of tinnitus. Am J Otol 20(5):627\u2013631. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10503585","journal-title":"Am J Otol"},{"issue":"5","key":"169_CR108","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1002\/lary.23485","volume":"124","author":"CF Sinclair","year":"2014","unstructured":"Sinclair CF, Gurey LE, Blitzer A (2014) Palatal myoclonus: algorithm for management with botulinum toxin based on clinical disease characteristics. Laryngoscope 124(5):1164\u20131169. https:\/\/doi.org\/10.1002\/lary.23485","journal-title":"Laryngoscope"},{"issue":"7","key":"169_CR109","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1097\/MAO.0000000000001090","volume":"37","author":"J Slengerik-Hansen","year":"2016","unstructured":"Slengerik-Hansen J, Ovesen T (2016) Botulinum toxin treatment of objective tinnitus because of essential palatal tremor: a systematic review. Otol Neurotol 37(7):820\u2013828. https:\/\/doi.org\/10.1097\/MAO.0000000000001090","journal-title":"Otol Neurotol"},{"issue":"3","key":"169_CR110","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1177\/0194599817711378","volume":"157","author":"H Staecker","year":"2017","unstructured":"Staecker H, Morelock M, Kramer T, Chrbolka P, Ahn JH, Meyer T (2017) Safety of repeated-dose intratympanic injections with AM-101 in acute inner ear tinnitus. Otolaryngol Head Neck Surg 157(3):478\u2013487. https:\/\/doi.org\/10.1177\/0194599817711378","journal-title":"Otolaryngol Head Neck Surg"},{"key":"169_CR111","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1472-6815-11-1","volume":"11","author":"M Suckfull","year":"2011","unstructured":"Suckfull M, Althaus M, Ellers-Lenz B, Gebauer A, Gortelmeyer R, Jastreboff PJ et al (2011) A randomized, double-blind, placebo-controlled clinical trial to evaluate the efficacy and safety of neramexane in patients with moderate to severe subjective tinnitus. BMC Ear Nose Throat Disord 11:1. https:\/\/doi.org\/10.1186\/1472-6815-11-1","journal-title":"BMC Ear Nose Throat Disord"},{"issue":"19","key":"169_CR112","doi-asserted-by":"publisher","first-page":"2251","DOI":"10.1001\/archinte.1993.00410190091011","volume":"153","author":"M Sullivan","year":"1993","unstructured":"Sullivan M, Katon W, Russo J, Dobie R, Sakai C (1993) A randomized trial of nortriptyline for severe chronic tinnitus. Effects on depression, disability, and tinnitus symptoms. Arch Intern Med 153(19):2251\u20132259. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8215728","journal-title":"Arch Intern Med"},{"issue":"4","key":"169_CR113","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1002\/lary.21461","volume":"121","author":"I Sziklai","year":"2011","unstructured":"Sziklai I, Szilvassy J, Szilvassy Z (2011) Tinnitus control by dopamine agonist pramipexole in presbycusis patients: a randomized, placebo-controlled, double-blind study. Laryngoscope 121(4):888\u2013893. https:\/\/doi.org\/10.1002\/lary.21461","journal-title":"Laryngoscope"},{"issue":"31","key":"169_CR114","doi-asserted-by":"publisher","first-page":"4866","DOI":"10.2174\/092986711797535254","volume":"18","author":"K Tabuchi","year":"2011","unstructured":"Tabuchi K, Nishimura B, Nakamagoe M, Hayashi K, Nakayama M, Hara A (2011) Ototoxicity: mechanisms of cochlear impairment and its prevention. Curr Med Chem 18(31):4866\u20134871. https:\/\/doi.org\/10.2174\/092986711797535254","journal-title":"Curr Med Chem"},{"issue":"9","key":"169_CR115","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1097\/MAO.0000000000002386","volume":"40","author":"A Taha","year":"2019","unstructured":"Taha A, Shlamkovitch N, Abu-Eta R, Yeheskeli E, Muallem-Kalmovich L, Gavriel H et al (2019) High dose of intratympanic steroids for sudden sensorineural hearing loss salvage. Otol Neurotol 40(9):1134\u20131138. https:\/\/doi.org\/10.1097\/MAO.0000000000002386","journal-title":"Otol Neurotol"},{"issue":"8","key":"169_CR116","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1080\/00016489.2018.1440086","volume":"138","author":"JA Tillinger","year":"2018","unstructured":"Tillinger JA, Gupta C, Ila K, Ahmed J, Mittal J, Van De Water TR et al (2018) l-N-acetylcysteine protects outer hair cells against TNFalpha initiated ototoxicity in vitro. Acta Otolaryngol 138(8):676\u2013684. https:\/\/doi.org\/10.1080\/00016489.2018.1440086","journal-title":"Acta Otolaryngol"},{"key":"169_CR117","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/S0079-6123(07)66028-2","volume":"166","author":"S Trellakis","year":"2007","unstructured":"Trellakis S, Lautermann J, Lehnerdt G (2007) Lidocaine: neurobiological targets and effects on the auditory system. Prog Brain Res 166:303\u2013322. https:\/\/doi.org\/10.1016\/S0079-6123(07)66028-2","journal-title":"Prog Brain Res"},{"issue":"2 Suppl","key":"169_CR118","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1177\/0194599814545325","volume":"151","author":"DE Tunkel","year":"2014","unstructured":"Tunkel DE, Bauer CA, Sun GH, Rosenfeld RM, Chandrasekhar SS, Cunningham ER Jr et al (2014) Clinical practice guideline: tinnitus. Otolaryngol Head Neck Surg 151(2 Suppl):S1\u2013S40. https:\/\/doi.org\/10.1177\/0194599814545325","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"2","key":"169_CR119","doi-asserted-by":"publisher","first-page":"115","DOI":"10.3766\/jaaa.23.2.6","volume":"23","author":"RS Tyler","year":"2012","unstructured":"Tyler RS (2012) Patient preferences and willingness to pay for tinnitus treatments. J Am Acad Audiol 23(2):115\u2013125. https:\/\/doi.org\/10.3766\/jaaa.23.2.6","journal-title":"J Am Acad Audiol"},{"key":"169_CR120","doi-asserted-by":"publisher","first-page":"CD010885","DOI":"10.1002\/14651858.CD010885.pub4","volume":"7","author":"JW van As","year":"2018","unstructured":"van As JW, van den Berg H, van Dalen EC (2018) Different infusion durations for preventing platinum-induced hearing loss in children with cancer. Cochrane Database Syst Rev 7:CD010885. https:\/\/doi.org\/10.1002\/14651858.CD010885.pub4","journal-title":"Cochrane Database Syst Rev"},{"key":"169_CR121","doi-asserted-by":"publisher","first-page":"CD009219","DOI":"10.1002\/14651858.CD009219.pub5","volume":"5","author":"JW van As","year":"2019","unstructured":"van As JW, van den Berg H, van Dalen EC (2019) Medical interventions for the prevention of platinum-induced hearing loss in children with cancer. Cochrane Database Syst Rev 5:CD009219. https:\/\/doi.org\/10.1002\/14651858.CD009219.pub5","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"169_CR122","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1097\/MAO.0000000000000268","volume":"35","author":"P van de Heyning","year":"2014","unstructured":"van de Heyning P, Muehlmeier G, Cox T, Lisowska G, Maier H, Morawski K et al (2014) Efficacy and safety of AM-101 in the treatment of acute inner ear tinnitus--a double-blind, randomized, placebo-controlled phase II study. Otol Neurotol 35(4):589\u2013597. https:\/\/doi.org\/10.1097\/MAO.0000000000000268","journal-title":"Otol Neurotol"},{"key":"169_CR123","doi-asserted-by":"publisher","first-page":"741452","DOI":"10.1155\/2014\/741452","volume":"2014","author":"W von der Behrens","year":"2014","unstructured":"von der Behrens W (2014) Animal models of subjective tinnitus. Neural Plast 2014:741452. https:\/\/doi.org\/10.1155\/2014\/741452","journal-title":"Neural Plast"},{"key":"169_CR124","doi-asserted-by":"publisher","unstructured":"Waissbluth S (2020) Clinical trials evaluating transtympanic otoprotectants for cisplatin-induced ototoxicity: what do we know so far? Eur Arch Otorhinolaryngol. https:\/\/doi.org\/10.1007\/s00405-020-06003-w","DOI":"10.1007\/s00405-020-06003-w"},{"key":"169_CR125","doi-asserted-by":"publisher","first-page":"CD013093","DOI":"10.1002\/14651858.CD013093.pub2","volume":"12","author":"I Wegner","year":"2018","unstructured":"Wegner I, Hall DA, Smit AL, McFerran D, Stegeman I (2018) Betahistine for tinnitus. Cochrane Database Syst Rev 12:CD013093. https:\/\/doi.org\/10.1002\/14651858.CD013093.pub2","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"169_CR126","first-page":"896","volume":"17","author":"BD Westerberg","year":"1996","unstructured":"Westerberg BD, Roberson JB Jr, Stach BA (1996) A double-blind placebo-controlled trial of baclofen in the treatment of tinnitus. Am J Otol 17(6):896\u2013903. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8915419","journal-title":"Am J Otol"},{"key":"169_CR127","doi-asserted-by":"publisher","first-page":"107826","DOI":"10.1016\/j.heares.2019.107826","volume":"384","author":"B Xiong","year":"2019","unstructured":"Xiong B, Liu Z, Liu Q, Peng Y, Wu H, Lin Y et al (2019) Missed hearing loss in tinnitus patients with normal audiograms. Hear Res 384:107826. https:\/\/doi.org\/10.1016\/j.heares.2019.107826","journal-title":"Hear Res"},{"issue":"36","key":"169_CR128","doi-asserted-by":"publisher","first-page":"14974","DOI":"10.1073\/pnas.1107998108","volume":"108","author":"S Yang","year":"2011","unstructured":"Yang S, Weiner BD, Zhang LS, Cho SJ, Bao S (2011) Homeostatic plasticity drives tinnitus perception in an animal model. Proc Natl Acad Sci U S A 108(36):14974\u201314979. https:\/\/doi.org\/10.1073\/pnas.1107998108","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"169_CR129","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.bj.2018.10.009","volume":"42","author":"CW Yeh","year":"2019","unstructured":"Yeh CW, Tseng LH, Yang CH, Hwang CF (2019) Effects of oral zinc supplementation on patients with noise-induced hearing loss associated tinnitus: a clinical trial. Biomed J 42(1):46\u201352. https:\/\/doi.org\/10.1016\/j.bj.2018.10.009","journal-title":"Biomed J"},{"issue":"3","key":"169_CR130","doi-asserted-by":"publisher","first-page":"E87","DOI":"10.1002\/lary.24360","volume":"124","author":"J Yoo","year":"2014","unstructured":"Yoo J, Hamilton SJ, Angel D, Fung K, Franklin J, Parnes LS et al (2014) Cisplatin otoprotection using transtympanic L-N-acetylcysteine: a pilot randomized study in head and neck cancer patients. Laryngoscope 124(3):E87\u2013E94. https:\/\/doi.org\/10.1002\/lary.24360","journal-title":"Laryngoscope"},{"key":"169_CR131","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1477-7525-12-7","volume":"12","author":"F Zeman","year":"2014","unstructured":"Zeman F, Koller M, Langguth B, Landgrebe M, Tinnitus Research Initiative database study group (2014) Which tinnitus-related aspects are relevant for quality of life and depression: results from a large international multicentre sample. Health Qual Life Outcomes 12:7. https:\/\/doi.org\/10.1186\/1477-7525-12-7","journal-title":"Health Qual Life Outcomes"},{"issue":"5","key":"169_CR132","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.1007\/s00405-016-4401-y","volume":"274","author":"HP Zenner","year":"2017","unstructured":"Zenner HP, Delb W, Kroner-Herwig B, Jager B, Peroz I, Hesse G et al (2017) A multidisciplinary systematic review of the treatment for chronic idiopathic tinnitus. Eur Arch Otorhinolaryngol 274(5):2079\u20132091. https:\/\/doi.org\/10.1007\/s00405-016-4401-y","journal-title":"Eur Arch Otorhinolaryngol"},{"issue":"6","key":"169_CR133","first-page":"453","volume":"50","author":"H Zhao","year":"2015","unstructured":"Zhao H, Dong H, Cheng Y, Ma Y, Lin P, Zhong S et al (2015) Multi-center study on the treatment of sudden deafness accompanied with tinnitus. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 50(6):453\u2013457. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26695794","journal-title":"Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi"},{"issue":"2","key":"169_CR134","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1159\/000487662","volume":"23","author":"C Zhu","year":"2018","unstructured":"Zhu C, Gausterer JC, Schopper H, Nieratschker M, Saidov N, Ahmadi N et al (2018) Evaluation of sustained-release steroid hydrogels in a guinea pig model for noise-induced hearing loss. Audiol Neurootol 23(2):73\u201381. https:\/\/doi.org\/10.1159\/000487662","journal-title":"Audiol Neurootol"},{"issue":"1","key":"169_CR135","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1097\/01.jcp.0000195111.86650.19","volume":"26","author":"S Zoger","year":"2006","unstructured":"Zoger S, Svedlund J, Holgers KM (2006) The effects of sertraline on severe tinnitus suffering--a randomized, double-blind, placebo-controlled study. J Clin Psychopharmacol 26(1):32\u201339. https:\/\/doi.org\/10.1097\/01.jcp.0000195111.86650.19","journal-title":"J Clin Psychopharmacol"}],"container-title":["Current Topics in Behavioral Neurosciences","The Behavioral Neuroscience of Tinnitus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/7854_2020_169","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,29]],"date-time":"2021-08-29T21:21:51Z","timestamp":1630272111000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/7854_2020_169"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"ISBN":["9783030855024","9783030855031"],"references-count":135,"URL":"https:\/\/doi.org\/10.1007\/7854_2020_169","relation":{},"ISSN":["1866-3370","1866-3389"],"issn-type":[{"value":"1866-3370","type":"print"},{"value":"1866-3389","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020]]},"assertion":[{"value":"7 August 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}